NO992968L - Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser - Google Patents

Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser

Info

Publication number
NO992968L
NO992968L NO992968A NO992968A NO992968L NO 992968 L NO992968 L NO 992968L NO 992968 A NO992968 A NO 992968A NO 992968 A NO992968 A NO 992968A NO 992968 L NO992968 L NO 992968L
Authority
NO
Norway
Prior art keywords
piperazinyl
preparation
new
benzoic acid
acid derivatives
Prior art date
Application number
NO992968A
Other languages
English (en)
Other versions
NO992968D0 (no
NO312896B1 (no
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Messangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO992968D0 publication Critical patent/NO992968D0/no
Publication of NO992968L publication Critical patent/NO992968L/no
Publication of NO312896B1 publication Critical patent/NO312896B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NO19992968A 1996-12-18 1999-06-17 Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt farmasöytiske preparater som omfatter dem NO312896B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (3)

Publication Number Publication Date
NO992968D0 NO992968D0 (no) 1999-06-17
NO992968L true NO992968L (no) 1999-08-17
NO312896B1 NO312896B1 (no) 2002-07-15

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992968A NO312896B1 (no) 1996-12-18 1999-06-17 Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt farmasöytiske preparater som omfatter dem

Country Status (26)

Country Link
US (1) US6281215B1 (no)
EP (1) EP0937054B1 (no)
JP (1) JP2001506645A (no)
KR (1) KR20000069544A (no)
CN (1) CN1073102C (no)
AR (1) AR013889A1 (no)
AT (1) ATE218558T1 (no)
AU (1) AU726640B2 (no)
BR (1) BR9713587A (no)
CA (1) CA2275346A1 (no)
CZ (1) CZ218999A3 (no)
DE (1) DE69713128T2 (no)
DK (1) DK0937054T3 (no)
ES (1) ES2178039T3 (no)
FR (1) FR2757158B1 (no)
HU (1) HUP0000586A3 (no)
ID (1) ID23671A (no)
NO (1) NO312896B1 (no)
PL (1) PL334187A1 (no)
PT (1) PT937054E (no)
RU (1) RU2178786C2 (no)
SK (1) SK282841B6 (no)
TR (1) TR199901367T2 (no)
UA (1) UA56206C2 (no)
WO (1) WO1998027078A1 (no)
ZA (1) ZA9711329B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) * 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same

Also Published As

Publication number Publication date
TR199901367T2 (xx) 1999-10-21
DK0937054T3 (da) 2002-09-16
JP2001506645A (ja) 2001-05-22
AU726640B2 (en) 2000-11-16
DE69713128D1 (de) 2002-07-11
HUP0000586A3 (en) 2002-10-28
ID23671A (id) 2000-05-11
AU5758298A (en) 1998-07-15
AR013889A1 (es) 2001-01-31
SK78599A3 (en) 2000-03-13
NO992968D0 (no) 1999-06-17
UA56206C2 (uk) 2003-05-15
CA2275346A1 (en) 1998-06-25
KR20000069544A (ko) 2000-11-25
FR2757158B1 (fr) 1999-04-02
FR2757158A1 (fr) 1998-06-19
CZ218999A3 (cs) 1999-09-15
DE69713128T2 (de) 2003-03-20
WO1998027078A1 (en) 1998-06-25
CN1073102C (zh) 2001-10-17
US6281215B1 (en) 2001-08-28
HUP0000586A2 (hu) 2001-04-28
ZA9711329B (en) 1998-06-24
ATE218558T1 (de) 2002-06-15
RU2178786C2 (ru) 2002-01-27
PL334187A1 (en) 2000-02-14
CN1245494A (zh) 2000-02-23
NO312896B1 (no) 2002-07-15
PT937054E (pt) 2002-11-29
EP0937054A1 (en) 1999-08-25
BR9713587A (pt) 2000-04-04
SK282841B6 (sk) 2002-12-03
EP0937054B1 (en) 2002-06-05
ES2178039T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
NO991761D0 (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO308660B1 (no) Nye 2,3-diketopiperazin-derivater eller deres salter, anvendelse derav og farmasøytisk preparat inneholdende slike
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
NO984717L (no) Nye hydroksamsyre-derivater, deres fremstilling og anvendelse
PT908458E (pt) Piridilmetilpiperazina substituida e derivados piperidina, sua preparacao e utilizacao para tratar as doencas do sistema nervoso central (cns)
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO20003965D0 (no) Nye dihydroksyheksansyre-derivater
NO984714D0 (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO951147D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
NO984713L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO992968L (no) Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser
NO994426D0 (no) Nye karboksylsyrederivater, deres fremstilling og anvendelse ved behandling av kreft
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
NO20014632L (no) Nye morfolinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende de nevnte derivater
NO980929L (no) Nye benzoksazindionderivater, fremgangsmÕte for deres fremstilling og deres anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO983829L (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
NO992209D0 (no) Nye Knoevenagel-kondensasjonsprodukter, fremgangsmÕte for deres fremstilling samt anvendelse derav
DK0452850T3 (da) 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO963129L (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse